PRUITT MICHAEL D (CEO, Chairman) purchased 4.0% of their position (200.00 shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $124.40 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/10/2019ACC: 0001493152-19-018968
DirectorOfficer· CEO, Chairman
Since Aug 2018
+200.00
Net shares
Net buyer
$124.40
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
200.00 acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+200.00
Price / share
$0.62
Trade value
$124.40
% of position
4.0%
12/10/2019
5.02K→5.22K
Total
Net shares
+200.00
Net value
$124.40
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/10/2019 | P · Purchase | +200.00 | $0.62 | $124.40 | 4.0% | 5.02K | 5.22K |
| Total | +200.00 | $124.40 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Series 1 Preferred Stock
IndirectShares owned340.00
Common Stock
DirectShares owned17.26K
Common Stock
IndirectShares owned33.46K
Total
17.26K direct·33.80K indirect51.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series 1 Preferred Stock | 340.00 | Indirect |
| Common Stock | 17.26K | Direct |
| Common Stock | 33.46K | Indirect |
| Total | 51.06K | 17.26K direct·33.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported